Why did Meta hire OpenAI researchers recently?
How did Trump gain veto power over U.S. Steel?
What caused U.S. economy to shrink in early 2025?
Why are Bitcoin ETFs seeing major inflows now?
How is AI reshaping marketing strategies?
What impact did U.S. strikes have on Iran's nuclear sites?
Why is Bumble cutting 30% of its workforce?
Altimmune Stock Sinks After Mid-Stage Data From Fatty Liver Candidate
benzinga.com/news/health-care/25/06/46116103/altimmune-stock-sinks-after-mid-stage-data-from-fatty-liver-candidate
On Thursday, Altimmune, Inc. (NASDAQ:ALT) released topline results from the IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH).
Treatment discontinuation rates were low, with 9% of participants prematurely discontinuing treatment.
In an…
This story appeared on benzinga.com, 2025-06-26 13:56:25.